CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...
Cambridge, United Kingdom and 7 other locations
can early detect pancreatic cancer in patients diagnosed with type 2 diabetes within the last 6 months.Participants will:* attend 3 study vi...
London, United Kingdom and 30 other locations
of type 1 diabetes.The primary objective is to determine whether vaccination of children with elevated genetic risk for type 1 diabetes...
Phase 4
Cambridge, United Kingdom and 8 other locations
People with type 1 diabetes sometimes develop heart failure which can cause symptoms like breathlessness, tiredness or ankle swelling, reduc...
Phase 2
London, United Kingdom and 16 other locations
also to as NMX8 system), in comparison with other commercially available AID systems (Automated insulin delivery) in adult patients with Type 1 diabetes...
Cambridge, United Kingdom and 20 other locations
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
London, United Kingdom and 96 other locations
To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...
London, United Kingdom and 89 other locations
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...
Phase 3
Stevenage, United Kingdom and 78 other locations
study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...
Phase 3
London, United Kingdom and 183 other locations
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...
Phase 3
London, United Kingdom and 78 other locations
Clinical trials
Research sites
Resources
Legal